Account
Watchlists
Bookmarks
Pricing
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Investor Presentation
Q2 FY26
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2025
Bearish
3
Neutral
8
Bullish
3
Bearish
21
Neutral
16
Bullish
9
Bearish
18
Neutral
8
Bullish
6
Market Cap
₹ 106 Cr
P/E
17.56
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
231.00 | 157 Cr | 84.31 | 5.86 | 0.00 | 0.52 | 4.98 | 0.33 | |
60.67 | 113 Cr | 25.01 | 3.30 | 0.00 | 13.19 | 14.48 | 12.18 | |
74.80 | 106 Cr | 17.56 | 2.11 | 0.00 | 0.00 | 0.00 | -1.10 | |
59.20 | 82 Cr | 31.49 | 2.26 | 0.00 | 5.09 | 6.48 | 3.76 | |
50.46 | 69 Cr | 16.33 | 1.73 | 0.00 | 9.17 | 11.55 | 7.01 | |
24.55 | 55 Cr | 87.68 | 1.11 | 0.00 | 1.67 | 4.07 | 1.30 | |
138.00 | 45 Cr | 35.11 | 3.70 | 0.00 | 9.84 | 10.99 | 4.13 |
Aakaar Medical Technologies Ltd. specializes in manufacturing and distributing medical aesthetic products and devices, targeting dermatologists, plastic surgeons, and other aesthetic practitioners.
The company launched its IPO in June 2025, raising INR 27 crores, which it is using to strengthen its working capital and expand its reach within the medical aesthetic industry.
Despite an 8.6% decline in revenue in H1FY26, the company is experiencing strong customer growth, adding 900+ new clients and expanding its product offerings to 154 SKUs.
Aakaar has formed strategic partnerships with international companies to distribute premium-quality aesthetic solutions in India, ensuring access to advanced products for its clients.
The introduction of new divisions, such as the high-margin EXOVEA range, signifies Aakaar's ambition to lead the evolution of India's aesthetic market through innovation and market expansion.
Healthcare
Hospitals / Medical Services
106 Cr
Low Risk
17.6
60.5
0.3
2.1
105.00
62.00
Sales CAGR
1Y
33.55%
3Y
46.80%
5Y
—
10Y
—
Profit CAGR
1Y
110.45%
3Y
55.11%
5Y
—
10Y
—
ROE
TTM
—
3Y
24.36%
5Y
21.74%
10Y
—
ROCE
TTM
—
3Y
38.35%
5Y
32.14%
10Y
—
Performance
STEADY PERFORMER
Valuation
REASONABLE
Growth
EXCEPTIONAL
Profitability
MODERATE MARGIN
Technicals
Bearish
Risk
MODERATE RISK
Board Meeting Outcome
3 days ago
Aakaar Medical Technologies Appoints New CFO
Aakaar Medical Technologies Limited has appointed Mr. Rakesh Parekh as Chief Financial Officer effective December 15, 2025.
Change in Directors/KMP
3 days ago
Aakaar Medical Technologies Limited - CFO Appointment
Aakaar Medical Technologies Limited appoints Mr. Rakesh Parekh as Chief Financial Officer (CFO) effective from 15th December 2025.
